Literature DB >> 2463386

Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies.

C Neyt1, J Geliebter, M Slaoui, D Morales, G Meulemans, A Burny.   

Abstract

The fusion gene sequence of six Newcastle disease virus escape mutants revealed that residues important for the integrity of antigenic site 1 and antigenic site 2 were located, respectively, on the F2 subunit and within the cysteine-rich domain of the F1 subunit. We further report the antibody-binding capacity of these mutants.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2463386      PMCID： PMC247772     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  27 in total

1.  Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants.

Authors:  J W Stave; J L Card; D O Morgan; V N Vakharia
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

2.  Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.

Authors:  B Blondel; R Crainic; O Fichot; G Dufraisse; A Candrea; D Diamond; M Girard; F Horaud
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  Natural feline leukemia virus variant escapes neutralization by a monoclonal antibody via an amino acid change outside the antibody-binding epitope.

Authors:  K Nicolaisen-Strouss; H P Kumar; T Fitting; C K Grant; J H Elder
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

4.  The nucleotide sequence of the gene encoding the F protein of canine distemper virus: a comparison of the deduced amino acid sequence with other paramyxoviruses.

Authors:  T Barrett; D K Clarke; S A Evans; B K Rima
Journal:  Virus Res       Date:  1987-11       Impact factor: 3.303

Review 5.  Influenza virus A pathogenicity: the pivotal role of hemagglutinin.

Authors:  R G Webster; R Rott
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

6.  Nucleotide sequence of the gene encoding the fusion glycoprotein of Newcastle disease virus.

Authors:  P Chambers; N S Millar; P T Emmerson
Journal:  J Gen Virol       Date:  1986-12       Impact factor: 3.891

7.  Expression at the cell surface of native fusion protein of the Newcastle disease virus (NDV) strain Italien from cloned cDNA.

Authors:  D Espion; S de Henau; C Letellier; C D Wemers; R Brasseur; J F Young; M Gross; M Rosenberg; G Meulemans; A Burny
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Monoclonal antibodies to hemagglutinin-neuraminidase and fusion glycoproteins of Newcastle disease virus: relationship between glycosylation and reactivity.

Authors:  L Long; D Portetelle; J Ghysdael; M Gonze; A Burny; G Meulemans
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

9.  Molecular cloning and nucleotide sequence of P, M and F genes of Newcastle disease virus avirulent strain D26.

Authors:  H Sato; M Oh-hira; N Ishida; Y Imamura; S Hattori; M Kawakita
Journal:  Virus Res       Date:  1987-05       Impact factor: 3.303

10.  Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus.

Authors:  T Toyoda; T Sakaguchi; K Imai; N M Inocencio; B Gotoh; M Hamaguchi; Y Nagai
Journal:  Virology       Date:  1987-05       Impact factor: 3.616
View more
  20 in total

1.  Intracellular processing of the paramyxovirus F protein: critical role of the predicted amphipathic alpha helix adjacent to the fusion domain.

Authors:  C Wang; G Raghu; T Morrison; M E Peeples
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Sequence analysis of temperature sensitive and "neuraminidase-tolerant" mutants of Newcastle disease virus (strain Beaudette C).

Authors:  J Hughes; K Yusoff; R Hardy; H McCartney; P T Emmerson; A C Samson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge.

Authors:  E Malvoisin; F Wild
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Characterization of a recombinant Newcastle disease virus vaccine strain.

Authors:  Sun-Hee Cho; Hyuk-Joon Kwon; Tae-Eun Kim; Jae-Hong Kim; Han-Sang Yoo; Man-Hoon Park; Young-Ho Park; Sun-Joong Kim
Journal:  Clin Vaccine Immunol       Date:  2008-09-03

5.  Genetic diversity of newcastle disease virus in wild birds and pigeons in West Africa.

Authors:  Chantal J Snoeck; Adeniyi T Adeyanju; Ademola A Owoade; Emmanuel Couacy-Hymann; Bello R Alkali; Ulf Ottosson; Claude P Muller
Journal:  Appl Environ Microbiol       Date:  2013-10-11       Impact factor: 4.792

6.  High genetic diversity of Newcastle disease virus in poultry in West and Central Africa: cocirculation of genotype XIV and newly defined genotypes XVII and XVIII.

Authors:  Chantal J Snoeck; Ademola A Owoade; Emmanuel Couacy-Hymann; Bello R Alkali; Mbah P Okwen; Adeniyi T Adeyanju; Giscard F Komoyo; Emmanuel Nakouné; Alain Le Faou; Claude P Muller
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

7.  Antigenic structure of human respiratory syncytial virus fusion glycoprotein.

Authors:  J A López; R Bustos; C Orvell; M Berois; J Arbiza; B García-Barreno; J A Melero
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

8.  Role of a single amino acid at the amino terminus of the simian virus 5 F2 subunit in syncytium formation.

Authors:  M Ito; M Nishio; M Kawano; S Kusagawa; H Komada; Y Ito; M Tsurudome
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

9.  Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein.

Authors:  K V Coelingh; E L Tierney
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

10.  Variation of a newcastle disease virus hemagglutinin-neuraminidase linear epitope.

Authors:  Sun-Hee Cho; Hyuk-Joon Kwon; Tae-Eun Kim; Jae-Hong Kim; Han-Sang Yoo; Sun-Joong Kim
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.